ISLET Act

Hozzl · 2023-12-07T17:05:52Z

Explore the details of Senate Bill 2205 ISLET Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/7/2023, 5:05 PM

Summary of Bill S 2205

The ISLET Act, also known as Bill 118 s 2205, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to establish a program within the Department of Health and Human Services that focuses on research and development related to islet cell transplantation.

Islet cell transplantation is a procedure that involves transferring insulin-producing cells from a donor pancreas into a person with type 1 diabetes. This treatment has shown promise in helping individuals with diabetes better manage their condition and potentially even cure it.

The ISLET Act aims to support and advance research in this area by providing funding for studies on islet cell transplantation, as well as promoting collaboration between researchers, healthcare providers, and patients. The bill also seeks to increase public awareness of the potential benefits of islet cell transplantation as a treatment for diabetes. Overall, the ISLET Act is focused on improving the lives of individuals with diabetes by advancing research and development in the field of islet cell transplantation. It is currently being reviewed by Congress and may potentially become law in the future.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2205

Bill S 2205 is currently in the status of Bill Introduced since June 22, 2023. Bill S 2205 was introduced during Congress 118 and was introduced to the Senate on June 22, 2023. Bill S 2205's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 22, 2023